Copyright
©The Author(s) 2023.
World J Gastroenterol. Mar 14, 2023; 29(10): 1569-1588
Published online Mar 14, 2023. doi: 10.3748/wjg.v29.i10.1569
Published online Mar 14, 2023. doi: 10.3748/wjg.v29.i10.1569
Figure 3 Immune check point inhibitors treatment for metastatic colorectal cancer.
CTLA4: Cytotoxic T-lymphocyte-associated protein 4; MHC: Major histocompatibility complex; PD-1: Programmed cell death protein 1; PD-L1: Programmed death-ligand; TCR: T cell receptor.
- Citation: Leowattana W, Leowattana P, Leowattana T. Systemic treatment for metastatic colorectal cancer. World J Gastroenterol 2023; 29(10): 1569-1588
- URL: https://www.wjgnet.com/1007-9327/full/v29/i10/1569.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i10.1569